Trial intelligence / Profile preview

Ferrous sulfate glycine sulfate enteric capsule vs iron polymaltose complex capsule in iron deficiency anemia

CTR20131398Phase 3Active

Sponsor
Sanol GmbH
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferroglycine sulfate in iron deficiency anemia (IDA), sponsored by Sanol GmbH. Started Aug 2014; status: active.

02

Drugs

ferroglycine sulfate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on CTR20131398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call